Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
Conditions
AML, Childhood · Acute Myeloid Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
First Affiliated Hospital Of University of Science and Technology of China, Hefei, Anhui, China
The Second Hospital of Anhui Medical University, Hefei, Anhui, China
Guangzhou Women and Children Medical Center, Guangzhou, Guangdong, China
The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
Kaifeng Children's Hospital, Kaifeng, Henan, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Third Xiangya Hospital of Central South University, Changsha, Hunan, China
XiangYa Hospital Central South University, Changsha, Hunan, China
Children's Hospital of Soochow University, Suzhou, Jiangsu, China
Contact: Principal Investigator (Shaoyan Hu, MD,PhD)Hailong HE, MD (Sub-investigator)YI Wang, MD,PhD (Sub-investigator)Jun Lu, MD,PhD (Sub-investigator)Peifang Xiao, MD,PhD (Sub-investigator)Jie Li, MD (Sub-investigator)Li Gao, MD (Sub-investigator)Xuzhou Children's Hospital, Xuzhou, Jiangsu, China
Qilu Hospital of Shandong University, Jinan, Shandong, China
Children's Hospital Of Fudan University, Shanghai, Shanghai Municipality, China
Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China
Study leads
Shaoyan Hu, MD, PhD
Study Chair
Children 's Hospital of Soochow University